Status:

COMPLETED

Improving Perioperative Sleep Disorders

Lead Sponsor:

Mengchang Yang

Conditions:

Sleep Disorder

Eligibility:

All Genders

18-65 years

Phase:

PHASE1

Brief Summary

In today's day of increasing surgical volume, perioperative sleep disorders are an issue that cannot be ignored. They are an important component of perioperative brain protection. Physiologically and ...

Detailed Description

Perioperative sleep disorders mainly refer to the syndrome in which patients undergoing surgery experience disrupted sleep wake rhythms before and/or after surgery, leading to abnormal sleep quality o...

Eligibility Criteria

Inclusion

  • 18 years old ≤ Age ≤ 65 years old, gender unlimited.
  • ASA level I-II.
  • Plan to undergo elective total knee arthroplasty, total hip arthroplasty, and spinal vertebral body surgery.

Exclusion

  • Patients with preoperative sleep problems.
  • Patients refuse to participate in the study.
  • The patient has any allergies or contraindications to the drugs used in the study.
  • The patient has a history of long-term use of medications such as pregabalin or gabapentin.
  • The patient has a history of long-term use of any painkillers or sleeping pills.
  • The patient has cognitive impairment and is unable to conduct visits and communication.
  • The patient has a history of renal dysfunction or any other serious organ dysfunction.

Key Trial Info

Start Date :

July 2 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 26 2024

Estimated Enrollment :

215 Patients enrolled

Trial Details

Trial ID

NCT06512155

Start Date

July 2 2024

End Date

December 26 2024

Last Update

December 30 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sichuan Provincial People's Hospita

Chengdu, Sichuan, China, 610000